An Open-Label, Randomized, 3-Period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX (Sumatriptan Succinate) Injection 4mg Administered Using the IMITREX STATdose System and a TREXIMA Tablet Followed by IMI.

Trial Profile

An Open-Label, Randomized, 3-Period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX (Sumatriptan Succinate) Injection 4mg Administered Using the IMITREX STATdose System and a TREXIMA Tablet Followed by IMI.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Naproxen sodium/sumatriptan; Sumatriptan; Sumatriptan
  • Indications Migraine
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 22 Apr 2009 Results presented at AAN 2009.
    • 17 Apr 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top